Navigation Links
German District Court Finds RENASYS™ GO NPWT System Non-infringing
Date:8/13/2010

litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.  Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof.  All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing.  Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

<> Trademark of Smith & Nephew.  Certain marks registered US Patent and Trademark Office.


'/>"/>
SOURCE Smith & Nephew Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008
5. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
6. Award-Winning Medical Technology From Germany
7. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
8. Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML (Mini-Laboratory) Instrument For Point-of-Care Testing at MEDICA 2009 In Dusseldorf, Germany
9. Tekia Enters Into Distribution Agreement With Fritz Ruck/T-MED, Germany to Market Its Accommodative Intraocular Lens to Treat Presbyopia
10. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
11. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... 2015 The scientific team of a ... of the leading academics in the field of aging Prof. ... in life extension for model animals - 10 fold for ... and age-related diseases, primarily, around the stability and stress resistance ... published as "Stability analysis of a model gene network links ...
(Date:8/28/2015)... Aug. 28, 2015 Perrigo Company plc ("Perrigo") ... Mylan N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote ... "Our views of Mylan,s offer to Perrigo shareholders ... on our Board,s careful reflection of the value available ... limited choices that Mylan has allowed its shareholders to ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Biosciences, Inc., a privately held company leading the development ... Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and ... President and Chief Scientific Officer, presented a poster about ... 17, 2010 at 9:30 a.m. CST in Chicago, IL. ...
... 2010 Reportlinker.com announces that a new market ... Global Contraceptives Industry ... the worldwide markets for Contraceptives in US$ Million ... Implants/ Injections, and Others. The report provides separate ...
Cached Medicine Technology:Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting 2Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting 3Reportlinker Adds Global Contraceptives Industry 2Reportlinker Adds Global Contraceptives Industry 3Reportlinker Adds Global Contraceptives Industry 4Reportlinker Adds Global Contraceptives Industry 5Reportlinker Adds Global Contraceptives Industry 6Reportlinker Adds Global Contraceptives Industry 7Reportlinker Adds Global Contraceptives Industry 8Reportlinker Adds Global Contraceptives Industry 9Reportlinker Adds Global Contraceptives Industry 10Reportlinker Adds Global Contraceptives Industry 11Reportlinker Adds Global Contraceptives Industry 12Reportlinker Adds Global Contraceptives Industry 13Reportlinker Adds Global Contraceptives Industry 14Reportlinker Adds Global Contraceptives Industry 15Reportlinker Adds Global Contraceptives Industry 16Reportlinker Adds Global Contraceptives Industry 17Reportlinker Adds Global Contraceptives Industry 18Reportlinker Adds Global Contraceptives Industry 19Reportlinker Adds Global Contraceptives Industry 20Reportlinker Adds Global Contraceptives Industry 21Reportlinker Adds Global Contraceptives Industry 22Reportlinker Adds Global Contraceptives Industry 23
(Date:8/30/2015)... Watertown, MA (PRWEB) , ... August 31, 2015 ... ... ChopChop Magazine: The Fun Cooking Magazine for Kids , recently elected two ... ChopChop’s bylaws. These appointments will further ChopChop’s mission of inspiring and teaching kids ...
(Date:8/30/2015)... ... ... Scientists in France say asbestos exposure may put workers at higher risk ... just posted an article on the new research. Click here to read it ... 2,024 French asbestos plant workers from 1978 to 2009. In addition to mesothelioma, the ...
(Date:8/30/2015)... , ... August 30, 2015 , ... ... has been promoted from Administrative assistant to Executive Assistant to CEO Mitch Gould ... a proven professional, focused on your goals. Kathleen graduated from Florida State ...
(Date:8/29/2015)... ... August 29, 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the ... (Meso Foundation) will present an educational program titled “Asbestos and Your Health.” , The ... PM (doors open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , Eau ... shipping costs. , “Before, a threshold of $49.00 was required to qualify for free ... qualify for free standard shipping for customers regardless of the item’s selling price.” , ...
Breaking Medicine News(10 mins):Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2
... thrombosis linked to deep vein thrombosis, study says , ... condition -- superficial vein thrombosis, or varicose veins that ... presence of a more dangerous problem. , One-quarter of ... study actually had deep vein thrombosis (DVT), a potentially ...
... metastasis, researchers say , MONDAY, July 20 (HealthDay News) ... contribute to aggressive breast cancer, new research shows. , ... of breast cancer tumors, researchers from the Genome Institute ... implicated in the development of breast cancer. , They ...
... , , , ... the "Door to Door" program for patients with multiple myeloma. Cancer Care ,s ... patients for covering transportation costs such as gasoline and taxi, bus or train ... The program is funded in part by a generous grant from ...
... , CBO Announcement Says Current Legislation Does Not ... , WASHINGTON, July 20 In response to a recent ... the Senate and House, the PFCD urges Congress to address the number-one ... , "The Senate HELP and House Ways ...
... School and Amtek, Hanover, NH may treat tumors that do ... on May 29th in the open access, peer reviewed journal ... to selectively kill tumors while protecting healthy cells. In ... as methylthioadenosine phosphorylase (MTAP) is missing in 35 to ...
... one of only four sites across the country to participate ... study will investigate the effectiveness of a chemotherapeutic agent, ThermoDox, ... therapy) for treating recurrent chest wall breast cancer. ... breast cancer on the chest wall, most commonly presenting in ...
Cached Medicine News:Health News:Vein Condition May Mask Serious Clot Disorder 2Health News:New Gene May Signal Aggressive Breast Cancer 2Health News:CancerCare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs 2Health News:CancerCare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs 3Health News:PFCD Urges Congress to Address Real Cost-Driver in Health Reform in Light of New CBO Statement 2Health News:New strategy in tumor treatment 2Health News:RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer 2